OC
RMTI icon

Oppenheimer & Co’s Rockwell Medical RMTI Stock Holding History

Oppenheimer & Co’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-106
Closed -$26K – 1382
2018
Q4 		$26K Sell
106
-46
-30% -$18.3K ﹤0.01% 1225
2018
Q3 		$70K Hold
152
– – ﹤0.01% 1319
2018
Q2 		$82K Sell
152
-23
-13% -$13.8K ﹤0.01% 1295
2018
Q1 		$100K Hold
175
– – ﹤0.01% 1288
2017
Q4 		$112K Hold
175
– – ﹤0.01% 1268
2017
Q3 		$165K Hold
175
– – ﹤0.01% 1209
2017
Q2 		$153K Sell
175
-10
-5% -$8.19K ﹤0.01% 1225
2017
Q1 		$127K Sell
185
-242
-57% -$159K ﹤0.01% 1232
2016
Q4 		$308K Sell
427
-62
-13% -$42.9K 0.01% 984
2016
Q3 		$361K Sell
489
-132
-21% -$107K 0.01% 921
2016
Q2 		$517K Sell
621
-15
-2% -$13.9K 0.02% 778
2016
Q1 		$526K Sell
636
-264
-29% -$207K 0.02% 734
2015
Q4 		$1.01M Buy
900
+53
+6% +$61.7K 0.03% 550
2015
Q3 		$719K Buy
847
+58
+7% +$84.1K 0.02% 682
2015
Q2 		$1.4M Buy
789
+25
+3% +$31.8K 0.04% 525
2015
Q1 		$919K Buy
+764
New +$895K 0.03% 656

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Oppenheimer & Co's RMTI Position: Q1 2019 in Review

Oppenheimer & Co sold out of Rockwell Medical (RMTI) in Q1 2019, closing a stake of 106 shares — an estimated $26K sold.

Oppenheimer & Co first reported a position in RMTI in Q1 2015 and held it in 16 quarters. The position peaked at $1.4M in Q2 2015. 84 funds tracked by Wall St. Rank hold RMTI as of Q1 2019.

  • Oppenheimer & Co reported no remaining Rockwell Medical position as of Q1 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 106 Rockwell Medical shares in Q1 2019, an estimated $26K.
  • Oppenheimer & Co first reported a position in Rockwell Medical in Q1 2015 and held it in 16 quarters.
  • Oppenheimer & Co's Rockwell Medical position peaked at $1.4M in Q2 2015.
  • 84 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2019.

Based on Oppenheimer & Co's 13F filing for Q1 2019, filed 24 Apr 2019.